Forian (NASDAQ:FORA) Stock Price Down 0.5% – Should You Sell?

Forian Inc. (NASDAQ:FORA)’s stock price traded down 0.5% during mid-day trading on Wednesday . The company traded as low as $2.04 and last traded at $2.04. 4,402 shares were traded during mid-day trading, a decline of 72% from the average session volume of 15,895 shares. The stock had previously closed at $2.05.

Forian Price Performance

The stock has a market capitalization of $63.47 million, a price-to-earnings ratio of 41.20 and a beta of 1.09. The firm’s fifty day moving average is $2.22 and its 200-day moving average is $2.48.

Forian (NASDAQ:FORA) last issued its earnings results on Wednesday, August 14th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.06). The firm had revenue of $4.78 million for the quarter, compared to analyst estimates of $5.26 million. During the same quarter in the previous year, the business posted ($0.03) EPS.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Forian stock. Caprock Group LLC purchased a new stake in Forian Inc. (NASDAQ:FORA) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund purchased 86,784 shares of the company’s stock, valued at approximately $230,000. Caprock Group LLC owned 0.28% of Forian as of its most recent filing with the SEC. Hedge funds and other institutional investors own 19.25% of the company’s stock.

Forian Company Profile

Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.